ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683628 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683628; 2) Community: the network communities that were significantly associated with the response to NSC 683628; 3) Molecule: the relationships between components within communities and NSC 683628; 4) MDR: the compounds that were significantly associated with the NSC 683628.

NSC Compound Enrichment Correlation
NSC 736802 Null 0.0342636096654271 0.077600926
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0342636096654271 0.037092909
NSC 743876 Null 0.0342636096654271 0.026552001
NSC 744063 Null 0.0342636096654271 0.085998812
NSC 748712 Null 0.0342636096654271 -0.02340418
NSC 749297 N'-{2-[2-(4-Methoxy-phenyl)-vinyl]quinazolin-4-yl}-N,N-dimethyl-propane-1,3-diamine hydrochloride 0.0342636096654271 -0.0808713
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0342636096654271 0.42150781
NSC 758881 Orlistat (USAN) 0.0342636096654271 0.049495066
NSC 759178 Pipamperone 0.0342636096654271 0.031435868
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0342636096654271 0.12527804
Total:120  Current:87    [First] [Prev] [Next] [Last]